Assaf Friedler
Impact in
- Virology top 1%
- HIV Research and Treatment
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- Protein Structure and Dynamics
- Chemical Synthesis and Analysis
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
- Virology 37
- HIV Research and Treatment 37
-
- Chemical Synthesis and Analysis 22
- Ubiquitin and proteasome pathways 18
- Protein Structure and Dynamics 17
- RNA Interference and Gene Delivery 12
- RNA modifications and cancer 12
- Co-authors
- Alan R. FershtStefan M.V. FreundDmitry B. VeprintsevAbraham LoyterZvi HayoukaStefan RüdigerOliver SchönMark Bycroft
- Journals
- Journal of Biological Chemistry (12 papers)Journal of Molecular Biology (10 papers)PLoS ONE (9 papers)Proceedings of the National Academy of Sciences (8 papers)Scientific Reports (6 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Assaf Friedler
141 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 118
- Virology 574
- Molecular Biology 3.2k
- Oncology 1.1k
- Biotechnology 248
- Infectious Diseases 481
Countries citing papers authored by Assaf Friedler
This map shows the geographic impact of Assaf Friedler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf Friedler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf Friedler more than expected).
Fields of papers citing papers by Assaf Friedler
This network shows the impact of papers produced by Assaf Friedler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf Friedler. The network helps show where Assaf Friedler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Assaf Friedler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 10 | |
| 7 | 2022 | 19 | |
| 8 | 2022 | 17 | |
| 9 | 2019 | 81 | |
| 10 | 2016 | 5 | |
| 11 | 2013 | 7 | |
| 12 | 2012 | 25 | |
| 13 | 2012 | 30 | |
| 14 | 2011 | 17 | |
| 15 | 2011 | 53 | |
| 16 | 2010 | 50 | |
| 17 | 2007 | 29 | |
| 18 | 2007 | 26 | |
| 19 | 2002 | 217 | |
| 20 | 2002 | 84 |
About Assaf Friedler
Assaf Friedler is a scholar working on Virology, Molecular Biology, Infectious Diseases, Oncology and Cell Biology, having authored 145 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (37 papers), HIV/AIDS drug development and treatment (28 papers), Chemical Synthesis and Analysis (22 papers), Cancer-related Molecular Pathways (21 papers), Ubiquitin and proteasome pathways (18 papers), Protein Structure and Dynamics (17 papers), RNA Interference and Gene Delivery (12 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Virology (574 citations), Molecular Biology (3.2k citations), Oncology (1.1k citations), Biotechnology (248 citations) and Infectious Diseases (481 citations). Assaf Friedler has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Alan R. Fersht, Stefan M.V. Freund, Dmitry B. Veprintsev, Abraham Loyter, Zvi Hayouka, Stefan Rüdiger, Oliver Schön, Mark Bycroft, Aviad Levin and Lars O. Hansson. Their work appears in journals such as Journal of Biological Chemistry, Journal of Molecular Biology, PLoS ONE, Proceedings of the National Academy of Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.